Skip to main content
Fig. 1 | Diabetology & Metabolic Syndrome

Fig. 1

From: Lower serum chromogranin B level is associated with type 1 diabetes and with type 2 diabetes patients with intensive conservative insulin treatment

Fig. 1

Serum chromogranin B (CgB) level of study subjects. In type 1 diabetes patients serum CgB levels were significantly lower than those in sex- and age-matched controls (a), whereas in type 2 diabetes (b) the 2 cohorts did not differ. Subgroup analysis depending on the type of therapy in type 2 diabetes (c) revealed that patients on intensive conservative insulin treatment had significantly lower serum CgB levels, compared to other regimens of therapy

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us